Kunisawa, Jun
National Institutes of Biomedical Innovation, Health and Nutrition,
Japan
2025 Rank: 72978
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1358 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 72978 | 78286 |
| Total Cites | 966 | 1072 |
| H-index | 11 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 77 | 78 |
| Number of Single+First+Last Authored Papers | 103 | 103 |
| Total Cites to Single+First+Last Authored Papers | 434 | 474 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 890 | 932 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.15 |
| Self-Citation Percentage |
9.89%
|
|
Kunisawa, Jun
National Institutes of Biomedical Innovation, Health and Nutrition,
Japan
2024 Rank: 70711
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1431 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70711 | 65818 |
| Total Cites | 893 | 1012 |
| H-index | 12 | 14 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 97 | 103 |
| Number of Single+First+Last Authored Papers | 99 | 99 |
| Total Cites to Single+First+Last Authored Papers | 367 | 421 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 782 | 822 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.23 |
| Self-Citation Percentage |
11.76%
|
|
Kunisawa, Jun
Osaka University,
Japan
2023 Rank: 68449
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1530 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68449 | 63320 |
| Total Cites | 818 | 980 |
| H-index | 13 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 96 | 111 |
| Number of Single+First+Last Authored Papers | 90 | 90 |
| Total Cites to Single+First+Last Authored Papers | 322 | 400 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 726 | 779 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.26 |
| Self-Citation Percentage |
16.53%
|
|
Kunisawa, Jun
National Institute of Biomedical Innovation,
Japan
2022 Rank: 109596
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2543 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 109596 | 103373 |
| Total Cites | 726 | 866 |
| H-index | 12 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 95 | 112 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 258 | 324 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 634 | 674 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.28 |
| Self-Citation Percentage |
16.17%
|
|
Kunisawa, Jun
National Institute of Biomedical Innovation,
Japan
2021 Rank: 80779
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1802 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 80779 | 74805 |
| Total Cites | 1009 | 1211 |
| H-index | 17 | 18 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 149 | 188 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 355 | 458 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 870 | 931 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.30 |
| Self-Citation Percentage |
16.68%
|
|
Kunisawa, Jun
National Institutes of Biomedical Innovation,
Japan
2020 Rank: 106628
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2160 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 106628 | 85392 |
| Total Cites | 660 | 829 |
| H-index | 13 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 106 | 143 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 167 | 236 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 573 | 635 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.31 |
| Self-Citation Percentage |
20.39%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.